Brexanolone as adjunctive therapy in super‐refractory status epilepticus

OBJECTIVE: Super‐refractory status epilepticus (SRSE) is a life‐threatening form of status epilepticus that continues or recurs despite 24 hours or more of anesthetic treatment. We conducted a multicenter, phase 1/2 study in SRSE patients to evaluate the safety and tolerability of brexanolone (USAN;...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Neurol
Autors principals: Rosenthal, Eric S., Claassen, Jan, Wainwright, Mark S., Husain, Aatif M., Vaitkevicius, Henrikas, Raines, Shane, Hoffmann, Ethan, Colquhoun, Helen, Doherty, James J., Kanes, Stephen J.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5639357/
https://ncbi.nlm.nih.gov/pubmed/28779545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars